Kaleido Biosciences, Inc.
DelistedCIK 1751299fmd_1R50K4T1MAG20T5MSP0C1S42ZEManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2018 to Dec 31, 2021, 16 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|
| Total revenues | – | – | 1 | 1 |
| Research and development | 42 | 64 | 56 | 68 |
| Total operating expenses | 61 | 87 | 80 | 89 |
| Operating income | (61) | (87) | (79) | (88) |
| Interest expense | 1 | 1 | 3 | 3 |
| Interest and investment income | 1 | 2 | 0 | 0 |
| Other non-operating income (expense) | (1) | 0 | (3) | (3) |
| Income tax expense | – | 0 | 0 | – |
| Net income | (62) | (86) | (82) | (90) |